Phivida Holdings Inc. (“Phivida” or the “Company“) (CSE:VIDA) is pleased to report a partnership with Superheroes Management (SHM) sports marketing agency; and the signing of World Surfing League gold medalist, Ms. Malia Manuel as Phivida’s Lead Brand Ambassador.
Mr. Jaimeson Keegan is the founder of SHM and is the former Director of Sports and Culture Marketing at Redbull. Mr. Keegan built a global roster of world-class athletes, musicians, celebrities at Redbull, managing the USA, Caribbean and Canada. Phivida is focused on building brand awareness within key markets across the Pacific coast. By adding SHM to the team, Phivida activates a sports endorsement initiative central to its global brand strategy.
As the inaugural SHM signing, Phivida is pleased to welcome Ms. Malia Manuel as the Lead Brand Ambassador. A native of Kauai Hawaii, and resident of Laguna California, Ms. Manuel is an active competitor on the World Surfing League circuit. In 2012 Malia Manuel became the youngest woman ever to win a gold medal in a World Surfing League Championship (WSJ) at the age of 14. Malia later became an icon within the southern California surfing culture. Other global lifestyle brands sponsoring Malia include; Lululemon, Jeep, O’Neil and Sanuk. Visit https://www.youtube.com/results?search_query=malia+manuel for coverage of Malia in past competition.
Phivida CEO John Belfontaine states; “we are proud to welcome Malia to the Phivida Team as our Lead Brand Ambassador. Malia embodies the spirit of Phivida as evidenced through her dedication to her sport, her ideals, and to her community. Malia is a fierce competitor, but more importantly, she’s a positive role model for young people around the world who dare to dream the impossible. We’re not just her sponsors, we’re also her fans.”
Phivida seeks to equip, empower and educate professional athletes, and active professionals with the option of using CBD-Hemp oil extract as an alternative to opiate-based pain killers to; optimize daily performance, treat chronic pain and inflammation-based conditions and to recover from training, and sports related injuries.
On January 1st 2018 the World Anti-Doping Agencies (WADA) officially removed cannabidiol (CBD) from their prohibited substances list. Phivida’s Nano-CBD™ is a natural opiate replacement therapy now available to athletes around the world, for the first time in the history of competitive sports. WADA’s decision comes in contrast to a rising global opiate epidemic, and the increased use of pain killers within professional and amateur sport.
SHM specializes in cultivating, fulfilling and activating strategic sports partnerships with lifestyle brands by connecting brands with iconic figures and elevating brand awareness through social and broadcast media. Superheroes Management athletes have won forty-seven (47) X-Games medals since their inception. For more information on SHM visit http://superheroesmgmt.com.
Phivida Holdings Inc.
Phivida (“fii-VEE-daa”) is a premier brand of cannabidiol (“CBD”) infused functional foods, beverages and clinical products. Using nanoencapsulation technology, Phivida converts phytocannabinoids into water soluble delivery format, enhancing bioavailability, and timed released within the body. Phivida’s Nano-CBD™ is infused into functional beverages, foods and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health conditions, from chronic pain to terminal diseases. The World Anti-Doping Association’s recent decision to lift its ban of CBD from hemp oil and the World Health Organization’s recent statement supports the clinical benefits of CBD for athletes worldwide. For more information visit www.phivida.com or join our social media rel=”nofollow”>network @Phivida. For investor inquiries please contact us via the information listed below.
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, the Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
CanBud Distribution Corporation Closes 2M Second and Final Tranche of its Oversubscribed Private Placement Offering
CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the final tranche of its oversubscribed non-brokered private placement for aggregate gross proceeds of approximately $4,730,000 (the “Offering”).
The Corporation issued a combined total of 39,409,346 units (each a “Unit“) at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.
Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands) announces that the letter of intent with Franchise Cannabis Corp. (“FCC”), previously announced in January, has been terminated. The previously announced European joint venture with FCC will continue and allow the Company to launch and tailor its products to European consumer demands
In connection with termination of the merger transaction with FCC, the Company has agreed to pay FCC $100,000 in cash and to issue FCC 5,000,000 common shares of the Company at a deemed value of $0.05 per share. The common shares will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.
Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.
Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value
Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).
Seattle Area Grocery Chain Metropolitan Market to Begin Carrying KOIOS and Fit Soda on March 22, 2021
Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.
Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.